NCT03216551View on ClinicalTrials.gov

Mediastinal Staging Accuracy of a Selective Lymphadenectomy Strategy in Early Stage NSCLC (ECTOP-1003)

CompletedOBSERVATIONAL
Enrollment

1,076

Participants

Timeline

Start Date

March 14, 2019

Primary Completion Date

May 30, 2022

Study Completion Date

May 30, 2022

Conditions
Lymph Node MetastasesNon-small Cell Lung Cancer Stage I
Interventions
DIAGNOSTIC_TEST

Intra-operative frozen section

Tumor histologic subtypes (whether it is lepidic predominant adenocarcinoma), N1 nodes metastasis (lymph nodes adjacent to the tumor will be sent to frozen section) and visceral pleural invasion will be determined by the intra-operative frozen section.

Trial Locations (1)

Unknown

Fudan University Shanghai Cancer Center, Shanghai

All Listed Sponsors
lead

Fudan University

OTHER

NCT03216551 - Mediastinal Staging Accuracy of a Selective Lymphadenectomy Strategy in Early Stage NSCLC (ECTOP-1003) | Biotech Hunter | Biotech Hunter